Pharmaceutical vs Research-Grade Bacteriostatic Water

Both products are sterile water with benzyl alcohol added at 0.9% as a preservative. The preservative suppresses the growth of organisms introduced when the stopper is punctured, so one vial can be entered more than once. Chemically, that is the whole formulation in both cases.

Everything else differs: who approved it, how it was made and released, what the label allows, and who it is sold to. The table sets the two side by side.

Bacteriostatic Water for Injection, USP is a human prescription drug. Its 30 mL vial label carries ‘Rx only’, the NDC 0409-3977-01 and the instruction ‘For drug diluent use only’. It is marketed under a New Drug Application, NDA 018802, held by Hospira, a Pfizer company.

When we checked the FDA’s National Drug Code Directory in October 2026, every bacteriostatic water product listed under an approved application referenced that same NDA. Other company names on those listings are distributors that relabel or repackage the approved product. This is why ‘Hospira bacteriostatic water’ is often used as shorthand for the drug product itself.

As a finished drug, it is made under the FDA’s current good manufacturing practice rules for pharmaceuticals, 21 CFR parts 210 and 211. ‘USP’ in the name means the product meets the United States Pharmacopeia monograph of that name. A pharmacy dispenses it against a prescription. Hospitals and clinics obtain it through drug distribution channels.

Research-grade bacteriostatic water is sold to laboratories as a reagent, a diluent and solvent for research and analytical work. It has no NDC and no approved application, and it is not represented as a USP drug product. Its label says what it is for: laboratory research use only, not for human or veterinary use.

Without an approved drug label behind it, a reagent’s quality has to be shown another way. The usual way is a certificate of analysis for each lot, issued by the laboratory that tested it. A useful certificate identifies and quantifies the preservative and reports sterility, endotoxin and pH, each with its method.

Our 30 mL vial is a reagent of this kind. A third-party manufacturer fills it, an independent laboratory tests each lot, and we publish the certificates. For lot EB61901, the release certificate reports benzyl alcohol at 0.921% against a 0.9% specification, sterility as a pass, endotoxins below 0.25 EU/mL against a specification of below 0.5 EU/mL, and pH within the 4.5 to 7.0 range.

How to read a certificate of analysis explains each line of that document. Every certificate for the lot in stock is on our Lab Testing & COA page, with the code the laboratory verifies it by.

The Federal Food, Drug, and Cosmetic Act defines a drug largely by what an article is meant for. Section 201(g)(1), codified at 21 U.S.C. 321(g)(1), includes ‘articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals’.

The FDA’s regulation on intended use, 21 CFR 201.128, says how that intent is judged. It is the objective intent of the people responsible for the labelling. It can be shown by labelling claims, advertising, written or oral statements, and the circumstances in which the product is sold.

In practice, a reagent supplier has to keep the label, the advertising and the sale consistent with research use. That is why our pages carry no dosing, protocols or use instructions. It is also why we never describe our product as a substitute for the drug product.

For the drug product, yes, a prescription is needed. Bacteriostatic Water for Injection, USP is labelled ‘Rx only’, so a pharmacy dispenses it only against a prescription. If a person or an animal needs bacteriostatic water, that is the route: a clinician prescribes it and a pharmacy fills it.

Bacteriostatic water is not a controlled substance, and buying it as a laboratory reagent for research is not illegal. The FDA drug label lists no DEA schedule. A reagent that is labelled, sold and bought for research is a different product, in a different channel, from the prescription drug.

What the rules turn on is intended use and labelling. A reagent that is labelled, promoted or sold for use in people or animals can be treated as a drug, whatever its label says, and an unapproved one. This is general information about how the rules are structured, not legal advice. Questions about a specific situation belong with a lawyer or your institution’s compliance office.

Hospira’s product is the approved drug. Research-grade bac water is a reagent. Both are sterile water with 0.9% benzyl alcohol, and the difference is everything around the liquid. On one side are the approved application, drug manufacturing rules, the NDC, prescription status and the approved label. On the other are the supplier’s specification, a certificate for each lot and research-use labelling.

Neither is a better version of the other. They are made for different purposes, and the reagent cannot be used in place of the drug product. If what you need is the drug product, the route is a prescription and a pharmacy. If you need a reagent for laboratory work, the route is a research supplier that publishes a certificate for the lot it ships. Where to buy bacteriostatic water compares those channels.

The label settles it. Look for these markings:

• ‘Rx only’ means a prescription drug.
• An NDC, a ten-digit code in three segments such as 0409-3977-01, means a product listed with the FDA as a drug.
• ‘Bacteriostatic Water for Injection, USP’ as the product name means the drug product.
• ‘For research use only’ or ‘Not for human or veterinary use’ means a laboratory reagent.
• A lot code you can match to a published certificate of analysis is how a reagent documents its quality.

For a reagent, the certificate is the part to read closely. It should name the lot on your vial and report each result with its method. Grade differences between bacteriostatic water, sterile water and water for injection are covered in bacteriostatic water vs sterile water.